Diagnosis and management of oral candidiasis

Otolaryngologic Clinics of North America

Volumn 44, Issue 1, 2011, Pages 231-240

  Giannini, Peter J ^a   Shetty, Kishore V ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Private Practice   (United States)

Author keywords

Candidiasis; Clinical presentation; Diagnosis; Immunocompromised; Management; Oral

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CLOTRIMAZOLE; CRYSTAL VIOLET; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; POTASSIUM HYDROXIDE;

CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CHEILITIS; CLINICAL FEATURE; GLOSSITIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; MORNING DOSAGE; MUCOCUTANEOUS CANDIDIASIS; PERIODIC ACID SCHIFF STAIN; REVIEW; RISK FACTOR; THRUSH;

ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; HUMANS;

EID: 78549238160     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2010.09.010     Document Type: Review

References (39)

1. Mohammad A.R., Giannini P.J. Oral candidiasis: current concepts in the diagnosis and management in the institutionalized elderly patient. A review. Dental Forum 2005, 33(2):65-70.
2. Samaranayake L.P., MacFarlane T.W. Oral candidosis 1990, Wright, London.
3. Zegarelli D.J. Fungal infections of the oral cavity. Otolaryngol Clin North Am 1993, 26:1069-1089.
4. Silverman S., Gallo J.W., McKnight M.L., et al. Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996, 82:402-407.
5. Vazquez J.A., Sobel J.D. Mucosal candidiasis. Infect Dis Clin North Am 2002, 16(4):793-820.
6. Neville B.W., Damm D.D., Allen C.M., et al. Fungal and protozoal diseases. Oral and maxillofacial pathology 1995, 166-167. WB Saunders, Philadelphia. 1st edition.
7. Pinheiro A., Marcenes W., Zakrzewska J.M., et al. Dental and oral lesions in HIV-infected patients: a study in Brazil. Int Dent J 2004, 54(3):131-137.
8. Ghannoum M.A., Radwan S.S. Candida adherence to epithelial cells 1990, CRC Press Inc, Boca Raton (FL).
9. Rossie K.M., Taylor J., Beck F.M., et al. Influence of radiation therapy on oral Candida albicans colonization: a quantitative assessment. Oral Surg Oral Med Oral Pathol 1987, 64:698-701.
10. Silverman S., Luangjarmekorn L., Greenspan D. Occurrence of oral Candida in irradiated head and neck cancer patients. J Oral Med 1984, 39:194-196.
11. Lockhart S.R., Joly S., Vargas K., et al. Natural defenses against Candida colonization breakdown in the oral cavities of the elderly. J Dent Res 1999, 78(4):857-868.
12. Epstein J.B., Komiyama K., Duncan D. Oral topical steroids and secondary oral candidiasis. J Oral Med 1986, 41:223-227.
13. Bonacini M., Young T., Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection: a prospective study of 110 patients. Arch Intern Med 1991, 151:1567-1572.
14. Farizo K.M., Buehler J.W., Chamberland M.E., et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992, 267:1798-1805.
15. Rabeneck L., Laine L. Esophageal candidiasis in patients infected with the human immunodeficiency virus. Arch Intern Med 1994, 154:2705-2710.
16. Budtz-Jorjenson E. Oral candidosis. Candida-associated denture stomatitis and angular cheilitis 1990, 156-183. Wright, London. L.P. Samaranayake, T.W. MacFarlane (Eds.).
17. Newton A.V. Denture sore mouth: a possible aetiology. Br Dent J 1962, 112:357-360.
18. Glass R.T., Bullard J.W., Hadley C.S., et al. Partial spectrum of microorganisms found in dentures and possible disease implications. J Am Osteopath Assoc 2001, 101(2):92-94.
19. Rose J.A. Folic-acid deficiency as a cause of angular cheilosis. Lancet 1971, 2(7722):453-454.
20. Samaranayake L.P., Holmstrup P. Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 1989, 18:554-564.
21. Neville B.W., Damm D.D., Allen C.M., et al. Fungal and protozoal diseases. Oral and maxillofacial pathology 2009, 216-219. WB Saunders, Philadelphia. 3rd edition.
22. Holmstrup P., Bessermann M. Clinical, therapeutic and pathogenic aspects of chronic oral multifocal candidiasis. Oral Surg Oral Med Oral Pathol 1983, 56:388-395.
23. World Health Organization.Adenoid squamous cell carcinoma Histological typing of cancer and precancer of the oral mucosa 1997, 21-31. Springer-Verlag, Berlin. 2nd edition. J.J. Pindborg, P.A. Reichart, C.J. Smith (Eds.).
24. Kirkpatrick C.H. Candidiasis, pathogenesis, diagnosis and treatment. Chronic mucocutaneous candidosis 1993, 167-183. Raven Press Ltd, New York. G.P. Bodey (Ed.).
25. Lilic D., Cant A.J., Abinum M., et al. Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-gamma) production. Clin Exp Immunol 1996, 105:205-212.
26. Rautemaa R., Hietanen J., Niissalo S., et al. Oral and esophageal squamous cell carcinoma-a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-1). Oral Oncol 2007, 43:607-613.
27. Feigal D.W., Katz M.H., Greenspan D. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991, 5:519-525.
28. Greenspan D. Treatment of oropharyngeal candidosis in HIV-positive patients. J Am Acad Dermatol 1994, 31:S51-S55.
29. Begg M.D., Panageas K.S., Mitchell-Lewis D., et al. Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996, 82:276-283.
30. Arendorf T.M., Bredekamp B., Cloete C.A., et al. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 1998, 27:176-179.
31. Kolokotronis A., Kioses V., Antoniades D., et al. Immunologic status in patients infected with HIV and oral candidiasis and hairy leukoplakia and median rhomboid glossitis. An oral manifestation in patients infected with HIV. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1994, 78:36-46.
32. Ellepola A.N., Samaranayake L.P. Oral candidal infections and actinomycotics. Crit Rev Oral Biol Med 2000, 11(2):172-198.
33. Umadevi M., Adeyemi O., Patel M., et al. Periodontal diseases and other bacterial infections. Adv Dent Res 2006, 19:139-145.
34. Mohammad A.R. Physical evaluation, diagnosis and management of oral conditions in the elderly patient. Geriatric dentistry 2010, 237-238. 6th edition. 2010.
35. Williams D.W., Lewis M.A. Isolation and identification of Candida from the oral cavity. Oral Dis 2000, 6:3-11.
36. Lamey P.J., Darwaza A., Fisher B.M., et al. Secretor status, candidal carriage and candidal infection in patients with diabetes mellitus. J Oral Pathol 1988, 17:354-357.
37. Johnston R.D., Chick E.W., Johnston N.S., et al. Asymptomatic quantitative increase of Candida albicans in the oral cavity: predisposing conditions. South Med J 1967, 43:903.
38. Epstein J.B., Pearsall N.N., Truelove E.J. Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects. J Clin Microbiol 1980, 12:475-476.
39. Kauffman C.A., Jones P.G. Candidiasis (a diagnostic and therapeutic challenge). Postgrad Med J 1986, 180:129-133.